Attilio Rovelli
Overview
Explore the profile of Attilio Rovelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
2240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Consiglieri G, Tucci F, De Pellegrin M, Guerrini B, Cattoni A, Risca G, et al.
Sci Transl Med
. 2024 May;
16(745):eadi8214.
PMID: 38691622
Mucopolysaccharidosis type I Hurler (MPSIH) is characterized by severe and progressive skeletal dysplasia that is not fully addressed by allogeneic hematopoietic stem cell transplantation (HSCT). Autologous hematopoietic stem progenitor cell-gene...
2.
Cattoni A, Molinari S, Gaiero A, De Lorenzo P, Fichera G, Riva B, et al.
Transplant Cell Ther
. 2022 Jun;
28(8):506.e1-506.e12.
PMID: 35660063
Thyroid late effects are among the most frequent sequelae reported after pediatric hematopoietic stem cell transplantation (HSCT). Although the detrimental effects of radiotherapy on the developing thyroid gland have been...
3.
Gentner B, Tucci F, Galimberti S, Fumagalli F, De Pellegrin M, Silvani P, et al.
N Engl J Med
. 2021 Nov;
385(21):1929-1940.
PMID: 34788506
Background: Allogeneic hematopoietic stem-cell transplantation is the standard of care for Hurler syndrome (mucopolysaccharidosis type I, Hurler variant [MPSIH]). However, this treatment is only partially curative and is associated with...
4.
Napolitano S, Ottaviano G, Bettini L, Russotto V, Bonanomi S, Rovelli A, et al.
Tumori
. 2021 Oct;
108(6):556-562.
PMID: 34674588
Background: Cytokine release syndrome (CRS) is a major complication after chimeric-antigen receptor T-cell treatment, characterized by an uncontrolled systemic inflammatory reaction. We investigated the potential role of diclofenac in the...
5.
Pontesilli S, Baldoli C, Della Rosa P, Cattoni A, Bernardo M, Meregalli P, et al.
J Pediatr
. 2021 Sep;
240:297-301.e5.
PMID: 34547335
We developed a brain and spine magnetic resonance scoring system based on a magnetic resonance assessment of 9 patients with mucopolysaccharidosis type I-Hurler who underwent hematopoietic stem-cell transplantation. The score...
6.
Ottaviano G, Achini-Gutzwiller F, Kalwak K, Lanino E, Faraci M, Rao K, et al.
Transplant Cell Ther
. 2021 Aug;
27(12):1020.e1-1020.e5.
PMID: 34450334
Peripheral blood stem cell transplantation (PBSCT) with in vivo lymphodepletion can provide faster neutrophil recovery with limited risk of severe graft-versus-host disease (GVHD) in children with nonmalignant disorders (NMDs). We...
7.
Cattoni A, Chiaraluce S, Gasperini S, Molinari S, Biondi A, Rovelli A, et al.
Mol Genet Metab Rep
. 2021 Aug;
28:100787.
PMID: 34408967
The impact of hematopoietic stem cell transplantation (HSCT) on growth in patients diagnosed with mucopolysaccharidosis I Hurler (MPS-IH) has been historically regarded as unsatisfactory. Nevertheless, the growth patterns recorded in...
8.
Costamagna G, Bove V, Ruggiero A, Rovelli A, Tringali A
VideoGIE
. 2021 Apr;
6(4):176-177.
PMID: 33898895
No abstract available.
9.
Nucera S, Fazio G, Piazza R, Rigamonti S, Fontana D, Passerini C, et al.
Hemasphere
. 2020 Nov;
4(5):e460.
PMID: 33163904
Supplemental Digital Content is available in the text.
10.
Faulkner L, Verna M, Rovelli A, Agarwal R, Dhanya R, Parmar L, et al.
Bone Marrow Transplant
. 2020 Sep;
56(3):536-543.
PMID: 32893265
Severe blood disorders and cancer are the leading cause of death and disability from noncommunicable diseases in the global pediatric population and a major financial burden. The most frequent of...